About Inversion Therapeutics
Inversion Therapeutics is a private company based in Burlingame, California, incorporated in 2024 in Delaware. It has reported $6,910,684 raised in one offering on Form D since August 2025.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 20, 2025 | Aug 27, 2025 | $6,910,684of $11.1M target | 4 | $1.7M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Inversion Therapeutics's Form D filed Aug 27, 2025.
SD
Samad Wahid, M.D.
Director
JD
James Wells, Ph.D.
President and director
JD
Jeremy Caldwell, Ph.D.
President and director
WD
William Kavanaugh, M.D.
Director